ArticleInternational cancer conference journal2022

Pathologic complete response with pembrolizumab plus axitinib in metastatic renal cell carcinoma.

Kazuki Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.